Cagrilintide vs tirzepatide Tirzepatide is a dual GIP/GLP-1 agonist that produces the highest monotherapy weight loss results currently available, approximately 22.5% at the maximum dose
The 12mg research format supports extended experimental protocols while reducing variability between peptide batches
However, it is essential to interpret this result with caution, as the EBGM05 for GLP-1RA-associated suicide/self-injury in children was lower than 2, suggesting a lack of robust signal strength
FAQ #3: What macros are needed for muscle gain
BioMedicine, 11 (2), 5-10
10) Practical dosing guardrails (for adults) Typical ceiling: 3,0004,000 mg/day total from all sources